F054 DataDerm Discoveries: How Registry Data Are Powering Real-World Research, AI Applications, and Inspiring Your Next Study
DESCRIPTION
The AAD’s clinical data registry, DataDerm, enables real-world research that advances understanding of dermatologic disease, treatment patterns, and patient populations, while also supporting emerging analytic approaches, including artificial intelligence (AI). This session will highlight the evolution of DataDerm, review the scope and structure of data available within DataDerm and examine how these data have been used to generate clinically relevant research findings and specialty-level insights.
Participants will hear from researchers who have leveraged DataDerm data to evaluate disease characteristics, treatment patterns, and variation in care. The session will also outline considerations for using registry data to explore research questions and improve patient care.
LEARNING OBJECTIVES
Identify the types of clinical, treatment, and patient data available within the DataDerm registry that support real-world research.
Describe how registry data have been used to generate real-world evidence and specialty insights related to dermatologic disease and treatment patterns.
Apply registry data concepts to develop research question
DIRECTOR
Steven Daniel Daveluy, MD, FAAD
Wayne State University School of Medicine
SPEAKER
Sylvia L. Parra, MD, FAAD
Dermatology and Skin Surgery
DISCLOSURES
Steven Daniel Daveluy, MD, FAAD
AbbVie – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Incyte – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Insmed – Investigator(Grants/Research Funding); Leo Pharma – Advisory Board(Honoraria), Investigator(Grants/Research Funding); MoonLake Immunotherapeutics – Investigator(Grants/Research Funding); Novartis – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Takeda Pharmaceuticals USA Inc – Investigator(Grants/Research Funding); UCB – Consultant(Fees), Investigator(Grants/Research Funding), Speaker(Honoraria);
Sylvia L. Parra, MD, FAAD
No financial relationships exist with ineligible companies.